Laboratory of Chemical Genomics, Engineering Laboratory for Chiral Drug Synthesis, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Xili, Nanshan District, Shenzhen, 518055, China.
Angew Chem Int Ed Engl. 2016 Oct 10;55(42):13263-13266. doi: 10.1002/anie.201606679.
Nannocystin A, a structurally unique 21-membered macrocyclic depsipeptide with low nanomolar inhibitory activity against elongation factor 1A, was synthesized according to a strategy involving the vinylogous Mukaiyama aldol reaction, Sharpless epoxidation, olefin metathesis, the Mitsunobu reaction, and a palladium-catalyzed intramolecular Suzuki coupling of a highly complex cyclization substrate. The overall synthesis is efficient and paves the way for preparation of analogues for drug development efforts.
纳诺菌素 A 是一种结构独特的 21 元环脂肽,对延伸因子 1A 的抑制活性达到纳摩尔级,其合成策略涉及 vinylogous Mukaiyama 醛醇反应、Sharpless 环氧化、烯烃复分解、Mitsunobu 反应以及高度复杂的环化底物的钯催化分子内 Suzuki 偶联反应。该全合成方法高效,为药物开发工作中制备类似物铺平了道路。